• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Brigatinib
    1 Drug classified under this active ingredient

    All the Active Ingredient Drugs

    Alunbrig® 30, 90 mg
    partial basket chart
    Alunbrig® 30, 90 mg

    Protein Kinase Inhibitor. Brigatinib 30 mg, 90 mg.
    F.C. TABS.: 30. The recom. dose regimen for is: 90 mg×1/d for the first 7 days;
    If 90 mg is tolerat. during the first 7 d, incr. the dose to 180 mg ×1/d.
    Admin. will cont. until dis. progres. or unaccept. toxicity.
    If Brigatinib is interrupt. for 14 d. or longer for reasons other than ADR's, resume tmt. at 90 mg ×1/d for 7 d. before incr. to the prev. tolerated dose.
    Tmt. of pts. with anaplastic lymphoma kinase (ALK)-positive metastat. non-small cell lung cancer (NSCLC) who have progres. on or are intolerant to crizotinib.
    C/I: Hypersens.